500594-06-9

Upstream product

• 500594-04-7 (3S,4S)-4-Benzyloxy-1-[1,3]dithian-2-yl-6-[(4S,5S)-5-(2-[1,3]dithian-2-yl-ethyl)-2,2-dimethyl-[1,3]dioxolan-4-yl]-hexan-3-ol 
• 500593-99-7 (E)-3-[(1S,2S)-2-Benzyloxy-4-[(4S,5S)-2,2-dimethyl-5-(3-oxo-propyl)-[1,3]dioxolan-4-yl]-1-(3-oxo-propyl)-butoxy]-acrylic acid ethyl ester 
• 500594-03-6 (1S,4S)-4-Benzyloxy-1,4-bis-((S)-5-methoxy-tetrahydro-furan-2-yl)-butan-1-ol 
• 500594-00-3 (4S,5S,8S,9S)-1,1,12,12-Tetramethoxy-dodecane-4,5,8,9-tetraol 
• 500594-02-5 (1S,4S)-1,4-Bis-((S)-5-methoxy-tetrahydro-furan-2-yl)-butane-1,4-diol 
• 60391-93-7 (4E,8E)-dodeca-4,8-dienedial 
• 63284-80-0 1,1,12,12-tetramethoxy-dodeca-4t,8t-diene 

Downstream Products

• 500594-07-0 {(2S,3R,6S)-6-[(1S,4S)-1-Benzyloxy-4-methoxymethoxy-4-((S)-5-methoxy-tetrahydro-furan-2-yl)-butyl]-3-methoxymethoxy-tetrahydro-pyran-2-yl}-acetic acid ethyl ester 
• 500594-14-9 (S)-3-((R)-2-(tert-Butyl-diphenyl-silanyloxy)-9-{(2R,5S)-5-[(1S,4S)-4-((2S,5R,6S)-6-decyl-5-methoxymethoxy-tetrahydro-pyran-2-yl)-1,4-bis-methoxymethoxy-butyl]-tetrahydro-furan-2-yl}-nonyl)-5-methyl-5H-furan-2-one 
• 500594-13-8 (S)-3-((E)-(R)-2-(tert-Butyl-diphenyl-silanyloxy)-9-{(2S,5S)-5-[(1S,4S)-4-((2S,5R,6S)-6-decyl-5-methoxymethoxy-tetrahydro-pyran-2-yl)-1,4-bis-methoxymethoxy-butyl]-tetrahydro-furan-2-yl}-non-5-en-7-ynyl)-5-methyl-5H-furan-2-one 
• 500594-15-0 (2S,3R,6S)-6-[(1S,4S)-1-Benzyloxy-4-methoxymethoxy-4-((S)-5-methoxy-tetrahydro-furan-2-yl)-butyl]-2-((Z)-dec-2-enyl)-3-methoxymethoxy-tetrahydro-pyran 

Relevant academic research and scientific papers

Stereoselective total synthesis of mucocin, an antitumor agent

The THP and THF rings which are regarded as the characteristic structural features of mucocin (1) were constructed by a SmI2-induced reductive cyclization of β-alkoxy acrylate and oxidative cyclization of a homoallyl alcohol, respectively. The